nodes	percent_of_prediction	percent_of_DWPC	metapath
Calcitriol—CYP3A4—Temozolomide—malignant glioma	0.453	1	CbGbCtD
Calcitriol—CYP24A1—Oxidation by Cytochrome P450—POR—malignant glioma	0.028	0.0719	CbGpPWpGaD
Calcitriol—CYP24A1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.0156	0.0399	CbGpPWpGaD
Calcitriol—Sensory disturbance—Temozolomide—malignant glioma	0.0154	0.1	CcSEcCtD
Calcitriol—VDR—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.013	0.0334	CbGpPWpGaD
Calcitriol—CYP24A1—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.00987	0.0253	CbGpPWpGaD
Calcitriol—CYP24A1—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.00974	0.025	CbGpPWpGaD
Calcitriol—CYP24A1—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.00856	0.022	CbGpPWpGaD
Calcitriol—CYP24A1—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.00845	0.0217	CbGpPWpGaD
Calcitriol—CYP24A1—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.008	0.0205	CbGpPWpGaD
Calcitriol—VDR—Validated transcriptional targets of TAp63 isoforms—PLK1—malignant glioma	0.00765	0.0196	CbGpPWpGaD
Calcitriol—CYP24A1—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.00694	0.0178	CbGpPWpGaD
Calcitriol—Apathy—Temozolomide—malignant glioma	0.0067	0.0434	CcSEcCtD
Calcitriol—Flat affect—Temozolomide—malignant glioma	0.00664	0.0431	CcSEcCtD
Calcitriol—VDR—Validated transcriptional targets of deltaNp63 isoforms—TOP2A—malignant glioma	0.00661	0.017	CbGpPWpGaD
Calcitriol—VDR—Validated transcriptional targets of TAp63 isoforms—PML—malignant glioma	0.00647	0.0166	CbGpPWpGaD
Calcitriol—VDR—Ovarian Infertility Genes—NCOR1—malignant glioma	0.00611	0.0157	CbGpPWpGaD
Calcitriol—VDR—Validated transcriptional targets of deltaNp63 isoforms—FBXW7—malignant glioma	0.00604	0.0155	CbGpPWpGaD
Calcitriol—VDR—Validated transcriptional targets of deltaNp63 isoforms—BDKRB2—malignant glioma	0.00593	0.0152	CbGpPWpGaD
Calcitriol—VDR—Regulation of nuclear SMAD2/3 signaling—RUNX3—malignant glioma	0.00588	0.0151	CbGpPWpGaD
Calcitriol—VDR—Validated transcriptional targets of TAp63 isoforms—JAG1—malignant glioma	0.00552	0.0142	CbGpPWpGaD
Calcitriol—CYP3A4—Liver X Receptor Pathway—CYP2B6—malignant glioma	0.00537	0.0138	CbGpPWpGaD
Calcitriol—CYP24A1—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.00526	0.0135	CbGpPWpGaD
Calcitriol—VDR—RXR and RAR heterodimerization with other nuclear receptor—PPARG—malignant glioma	0.00517	0.0133	CbGpPWpGaD
Calcitriol—CYP24A1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.00498	0.0128	CbGpPWpGaD
Calcitriol—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.00479	0.031	CcSEcCtD
Calcitriol—VDR—Validated transcriptional targets of deltaNp63 isoforms—BRCA2—malignant glioma	0.00478	0.0123	CbGpPWpGaD
Calcitriol—VDR—Validated transcriptional targets of deltaNp63 isoforms—HES1—malignant glioma	0.00452	0.0116	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—NDRG1—malignant glioma	0.00447	0.0115	CbGpPWpGaD
Calcitriol—VDR—RXR and RAR heterodimerization with other nuclear receptor—BCL2—malignant glioma	0.00428	0.011	CbGpPWpGaD
Calcitriol—CYP24A1—Biological oxidations—CYP2B6—malignant glioma	0.00425	0.0109	CbGpPWpGaD
Calcitriol—CYP24A1—Metapathway biotransformation—CYP2B6—malignant glioma	0.00419	0.0108	CbGpPWpGaD
Calcitriol—VDR—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.00417	0.0107	CbGpPWpGaD
Calcitriol—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.00399	0.0259	CcSEcCtD
Calcitriol—GC—Metabolism—RTEL1—malignant glioma	0.00391	0.01	CbGpPWpGaD
Calcitriol—VDR—Nuclear Receptors—PPARG—malignant glioma	0.00382	0.0098	CbGpPWpGaD
Calcitriol—CYP24A1—Biological oxidations—CYP2C18—malignant glioma	0.00369	0.00946	CbGpPWpGaD
Calcitriol—Thirst—Temozolomide—malignant glioma	0.00365	0.0237	CcSEcCtD
Calcitriol—CYP24A1—Metapathway biotransformation—CYP2C18—malignant glioma	0.00364	0.00933	CbGpPWpGaD
Calcitriol—CYP3A4—Oxidation by Cytochrome P450—POR—malignant glioma	0.00363	0.00933	CbGpPWpGaD
Calcitriol—VDR—Validated transcriptional targets of deltaNp63 isoforms—NOTCH1—malignant glioma	0.00341	0.00876	CbGpPWpGaD
Calcitriol—Dehydration—Temozolomide—malignant glioma	0.00323	0.0209	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—MSH2—malignant glioma	0.00323	0.00829	CbGpPWpGaD
Calcitriol—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00313	0.0203	CcSEcCtD
Calcitriol—CYP3A4—Xenobiotics—CYP2B6—malignant glioma	0.00309	0.00792	CbGpPWpGaD
Calcitriol—VDR—Regulation of nuclear SMAD2/3 signaling—CDKN2B—malignant glioma	0.00306	0.00787	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—PML—malignant glioma	0.00302	0.00775	CbGpPWpGaD
Calcitriol—VDR—Nuclear Receptor transcription pathway—PPARG—malignant glioma	0.00302	0.00774	CbGpPWpGaD
Calcitriol—CYP24A1—Biological oxidations—GSTT1—malignant glioma	0.00298	0.00765	CbGpPWpGaD
Calcitriol—VDR—Regulation of nuclear SMAD2/3 signaling—NCOR1—malignant glioma	0.00291	0.00746	CbGpPWpGaD
Calcitriol—Cholecalciferol—CYP2B6—malignant glioma	0.0028	1	CrCbGaD
Calcitriol—GC—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.0028	0.00718	CbGpPWpGaD
Calcitriol—CYP24A1—Biological oxidations—PTGS1—malignant glioma	0.00279	0.00717	CbGpPWpGaD
Calcitriol—VDR—RXR and RAR heterodimerization with other nuclear receptor—TNF—malignant glioma	0.00275	0.00705	CbGpPWpGaD
Calcitriol—Weight decreased—Temozolomide—malignant glioma	0.00272	0.0176	CcSEcCtD
Calcitriol—VDR—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—malignant glioma	0.00271	0.00695	CbGpPWpGaD
Calcitriol—GC—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.00271	0.00694	CbGpPWpGaD
Calcitriol—Urinary tract infection—Carmustine—malignant glioma	0.00269	0.0175	CcSEcCtD
Calcitriol—CYP3A4—Xenobiotics—CYP2C18—malignant glioma	0.00268	0.00687	CbGpPWpGaD
Calcitriol—VDR—Validated transcriptional targets of deltaNp63 isoforms—MDM2—malignant glioma	0.00263	0.00674	CbGpPWpGaD
Calcitriol—Urinary tract infection—Temozolomide—malignant glioma	0.0026	0.0169	CcSEcCtD
Calcitriol—CYP3A4—Irinotecan Pathway—BCHE—malignant glioma	0.00251	0.00643	CbGpPWpGaD
Calcitriol—Haemoglobin—Carmustine—malignant glioma	0.0025	0.0162	CcSEcCtD
Calcitriol—Haemorrhage—Carmustine—malignant glioma	0.00249	0.0161	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—BDKRB2—malignant glioma	0.00248	0.00635	CbGpPWpGaD
Calcitriol—VDR—Validated transcriptional targets of TAp63 isoforms—CDKN2A—malignant glioma	0.00242	0.00622	CbGpPWpGaD
Calcitriol—Haemoglobin—Temozolomide—malignant glioma	0.00242	0.0157	CcSEcCtD
Calcitriol—Haemorrhage—Temozolomide—malignant glioma	0.0024	0.0156	CcSEcCtD
Calcitriol—VDR—Validated transcriptional targets of TAp63 isoforms—MDM2—malignant glioma	0.00235	0.00603	CbGpPWpGaD
Calcitriol—Erythema multiforme—Temozolomide—malignant glioma	0.00227	0.0147	CcSEcCtD
Calcitriol—GC—Metabolism—COX8A—malignant glioma	0.00225	0.00577	CbGpPWpGaD
Calcitriol—CYP3A4—Tryptophan metabolism—ASMT—malignant glioma	0.00222	0.00571	CbGpPWpGaD
Calcitriol—Arrhythmia—Carmustine—malignant glioma	0.00222	0.0144	CcSEcCtD
Calcitriol—Erythema—Carmustine—malignant glioma	0.00216	0.014	CcSEcCtD
Calcitriol—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.00212	0.00544	CbGpPWpGaD
Calcitriol—Erythema—Temozolomide—malignant glioma	0.00209	0.0136	CcSEcCtD
Calcitriol—CYP24A1—Metabolism—RTEL1—malignant glioma	0.00209	0.00536	CbGpPWpGaD
Calcitriol—CYP24A1—Biological oxidations—GSTP1—malignant glioma	0.00207	0.0053	CbGpPWpGaD
Calcitriol—Dysgeusia—Temozolomide—malignant glioma	0.00205	0.0133	CcSEcCtD
Calcitriol—CYP24A1—Metapathway biotransformation—GSTP1—malignant glioma	0.00204	0.00523	CbGpPWpGaD
Calcitriol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.00202	0.00518	CbGpPWpGaD
Calcitriol—GC—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.00201	0.00516	CbGpPWpGaD
Calcitriol—Agitation—Carmustine—malignant glioma	0.00199	0.0129	CcSEcCtD
Calcitriol—Agitation—Temozolomide—malignant glioma	0.00192	0.0125	CcSEcCtD
Calcitriol—GC—Metabolism—ASMT—malignant glioma	0.00191	0.0049	CbGpPWpGaD
Calcitriol—Convulsion—Carmustine—malignant glioma	0.00188	0.0122	CcSEcCtD
Calcitriol—Hypertension—Carmustine—malignant glioma	0.00187	0.0121	CcSEcCtD
Calcitriol—GC—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.00187	0.00479	CbGpPWpGaD
Calcitriol—Myalgia—Carmustine—malignant glioma	0.00184	0.012	CcSEcCtD
Calcitriol—Chest pain—Carmustine—malignant glioma	0.00184	0.012	CcSEcCtD
Calcitriol—Anxiety—Carmustine—malignant glioma	0.00184	0.0119	CcSEcCtD
Calcitriol—VDR—Retinoic acid receptors-mediated signaling—AKT1—malignant glioma	0.00182	0.00468	CbGpPWpGaD
Calcitriol—Convulsion—Temozolomide—malignant glioma	0.00181	0.0118	CcSEcCtD
Calcitriol—Hypertension—Temozolomide—malignant glioma	0.00181	0.0117	CcSEcCtD
Calcitriol—GC—Metabolism—BCAN—malignant glioma	0.0018	0.00461	CbGpPWpGaD
Calcitriol—Myalgia—Temozolomide—malignant glioma	0.00178	0.0115	CcSEcCtD
Calcitriol—Anxiety—Temozolomide—malignant glioma	0.00177	0.0115	CcSEcCtD
Calcitriol—Discomfort—Temozolomide—malignant glioma	0.00176	0.0114	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—SPP1—malignant glioma	0.00174	0.00448	CbGpPWpGaD
Calcitriol—Dry mouth—Temozolomide—malignant glioma	0.00174	0.0113	CcSEcCtD
Calcitriol—Anaphylactic shock—Temozolomide—malignant glioma	0.00171	0.0111	CcSEcCtD
Calcitriol—Anorexia—Carmustine—malignant glioma	0.00168	0.0109	CcSEcCtD
Calcitriol—Skin disorder—Temozolomide—malignant glioma	0.00166	0.0108	CcSEcCtD
Calcitriol—Anorexia—Temozolomide—malignant glioma	0.00163	0.0106	CcSEcCtD
Calcitriol—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00161	0.0104	CcSEcCtD
Calcitriol—Insomnia—Carmustine—malignant glioma	0.0016	0.0104	CcSEcCtD
Calcitriol—Somnolence—Carmustine—malignant glioma	0.00157	0.0102	CcSEcCtD
Calcitriol—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00156	0.0101	CcSEcCtD
Calcitriol—Insomnia—Temozolomide—malignant glioma	0.00154	0.01	CcSEcCtD
Calcitriol—Decreased appetite—Carmustine—malignant glioma	0.00154	0.00996	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—CAV1—malignant glioma	0.00153	0.00393	CbGpPWpGaD
Calcitriol—Somnolence—Temozolomide—malignant glioma	0.00152	0.00984	CcSEcCtD
Calcitriol—Pain—Carmustine—malignant glioma	0.00151	0.0098	CcSEcCtD
Calcitriol—Constipation—Carmustine—malignant glioma	0.00151	0.0098	CcSEcCtD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.00149	0.00383	CbGpPWpGaD
Calcitriol—Decreased appetite—Temozolomide—malignant glioma	0.00148	0.00962	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—MET—malignant glioma	0.00148	0.0038	CbGpPWpGaD
Calcitriol—Pain—Temozolomide—malignant glioma	0.00146	0.00947	CcSEcCtD
Calcitriol—Constipation—Temozolomide—malignant glioma	0.00146	0.00947	CcSEcCtD
Calcitriol—GC—Metabolism—IDH2—malignant glioma	0.00145	0.00372	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.00144	0.00371	CbGpPWpGaD
Calcitriol—Gastrointestinal pain—Carmustine—malignant glioma	0.00144	0.00937	CcSEcCtD
Calcitriol—Abdominal pain—Carmustine—malignant glioma	0.0014	0.00906	CcSEcCtD
Calcitriol—Body temperature increased—Carmustine—malignant glioma	0.0014	0.00906	CcSEcCtD
Calcitriol—Gastrointestinal pain—Temozolomide—malignant glioma	0.0014	0.00905	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—APC—malignant glioma	0.00139	0.00358	CbGpPWpGaD
Calcitriol—CYP3A4—Tryptophan metabolism—CYP2C18—malignant glioma	0.00137	0.00353	CbGpPWpGaD
Calcitriol—GC—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.00137	0.00351	CbGpPWpGaD
Calcitriol—GC—Metabolism—CYP2B6—malignant glioma	0.00136	0.00349	CbGpPWpGaD
Calcitriol—CYP3A4—Irinotecan Pathway—APC—malignant glioma	0.00136	0.00349	CbGpPWpGaD
Calcitriol—Urticaria—Temozolomide—malignant glioma	0.00136	0.0088	CcSEcCtD
Calcitriol—Abdominal pain—Temozolomide—malignant glioma	0.00135	0.00875	CcSEcCtD
Calcitriol—Body temperature increased—Temozolomide—malignant glioma	0.00135	0.00875	CcSEcCtD
Calcitriol—Hypersensitivity—Carmustine—malignant glioma	0.0013	0.00844	CcSEcCtD
Calcitriol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.00128	0.00329	CbGpPWpGaD
Calcitriol—Asthenia—Carmustine—malignant glioma	0.00127	0.00822	CcSEcCtD
Calcitriol—CYP3A4—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.00126	0.00325	CbGpPWpGaD
Calcitriol—Hypersensitivity—Temozolomide—malignant glioma	0.00126	0.00816	CcSEcCtD
Calcitriol—GC—Metabolism—IDH1—malignant glioma	0.00125	0.0032	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—MMP2—malignant glioma	0.00123	0.00317	CbGpPWpGaD
Calcitriol—Asthenia—Temozolomide—malignant glioma	0.00123	0.00794	CcSEcCtD
Calcitriol—Diarrhoea—Carmustine—malignant glioma	0.00121	0.00784	CcSEcCtD
Calcitriol—Pruritus—Temozolomide—malignant glioma	0.00121	0.00783	CcSEcCtD
Calcitriol—GC—Metabolism—SPHK1—malignant glioma	0.00121	0.00309	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—COX8A—malignant glioma	0.0012	0.00308	CbGpPWpGaD
Calcitriol—VDR—Regulation of nuclear SMAD2/3 signaling—MYC—malignant glioma	0.00119	0.00305	CbGpPWpGaD
Calcitriol—GC—Metabolism—CYP2C18—malignant glioma	0.00118	0.00303	CbGpPWpGaD
Calcitriol—Diarrhoea—Temozolomide—malignant glioma	0.00117	0.00758	CcSEcCtD
Calcitriol—Vomiting—Carmustine—malignant glioma	0.00112	0.00728	CcSEcCtD
Calcitriol—Rash—Carmustine—malignant glioma	0.00111	0.00722	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—BCL2—malignant glioma	0.00111	0.00286	CbGpPWpGaD
Calcitriol—GC—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.00111	0.00286	CbGpPWpGaD
Calcitriol—Dermatitis—Carmustine—malignant glioma	0.00111	0.00722	CcSEcCtD
Calcitriol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.00111	0.00285	CbGpPWpGaD
Calcitriol—Headache—Carmustine—malignant glioma	0.00111	0.00718	CcSEcCtD
Calcitriol—VDR—Direct p53 effectors—MDM2—malignant glioma	0.0011	0.00282	CbGpPWpGaD
Calcitriol—CYP3A4—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.0011	0.00281	CbGpPWpGaD
Calcitriol—Vomiting—Temozolomide—malignant glioma	0.00109	0.00704	CcSEcCtD
Calcitriol—Rash—Temozolomide—malignant glioma	0.00108	0.00698	CcSEcCtD
Calcitriol—Dermatitis—Temozolomide—malignant glioma	0.00108	0.00697	CcSEcCtD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.00107	0.00275	CbGpPWpGaD
Calcitriol—Headache—Temozolomide—malignant glioma	0.00107	0.00694	CcSEcCtD
Calcitriol—Nausea—Carmustine—malignant glioma	0.00105	0.00681	CcSEcCtD
Calcitriol—CYP3A4—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.00104	0.00267	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—ASMT—malignant glioma	0.00102	0.00262	CbGpPWpGaD
Calcitriol—Nausea—Temozolomide—malignant glioma	0.00101	0.00658	CcSEcCtD
Calcitriol—GC—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.00101	0.0026	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000997	0.00256	CbGpPWpGaD
Calcitriol—VDR—Generic Transcription Pathway—NOTCH3—malignant glioma	0.000994	0.00255	CbGpPWpGaD
Calcitriol—GC—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000979	0.00251	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—BCAN—malignant glioma	0.000959	0.00246	CbGpPWpGaD
Calcitriol—GC—Metabolism—GSTT1—malignant glioma	0.000955	0.00245	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—PTEN—malignant glioma	0.000922	0.00237	CbGpPWpGaD
Calcitriol—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000901	0.00231	CbGpPWpGaD
Calcitriol—GC—Metabolism—PTGS1—malignant glioma	0.000895	0.0023	CbGpPWpGaD
Calcitriol—VDR—Generic Transcription Pathway—NOTCH2—malignant glioma	0.000892	0.00229	CbGpPWpGaD
Calcitriol—GC—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000891	0.00229	CbGpPWpGaD
Calcitriol—GC—Metabolism—BCHE—malignant glioma	0.000832	0.00213	CbGpPWpGaD
Calcitriol—VDR—Regulation of nuclear SMAD2/3 signaling—AKT1—malignant glioma	0.000824	0.00211	CbGpPWpGaD
Calcitriol—GC—Metabolism—SLC5A5—malignant glioma	0.000822	0.00211	CbGpPWpGaD
Calcitriol—GC—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000777	0.00199	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—IDH2—malignant glioma	0.000773	0.00198	CbGpPWpGaD
Calcitriol—GC—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.00077	0.00198	CbGpPWpGaD
Calcitriol—VDR—Generic Transcription Pathway—CDKN2B—malignant glioma	0.000766	0.00197	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—EGFR—malignant glioma	0.00075	0.00192	CbGpPWpGaD
Calcitriol—CYP3A4—Tryptophan metabolism—CAT—malignant glioma	0.000749	0.00192	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000729	0.00187	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—CYP2B6—malignant glioma	0.000727	0.00187	CbGpPWpGaD
Calcitriol—VDR—Generic Transcription Pathway—NCOR1—malignant glioma	0.000727	0.00187	CbGpPWpGaD
Calcitriol—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000682	0.00175	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—DNMT3B—malignant glioma	0.000679	0.00174	CbGpPWpGaD
Calcitriol—GC—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000671	0.00172	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—IDH1—malignant glioma	0.000665	0.00171	CbGpPWpGaD
Calcitriol—GC—Metabolism—GSTP1—malignant glioma	0.000662	0.0017	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—HIST1H3B—malignant glioma	0.00066	0.00169	CbGpPWpGaD
Calcitriol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000646	0.00166	CbGpPWpGaD
Calcitriol—GC—Metabolism—CAT—malignant glioma	0.000644	0.00165	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—SPHK1—malignant glioma	0.000643	0.00165	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—CYP2C18—malignant glioma	0.00063	0.00162	CbGpPWpGaD
Calcitriol—VDR—Direct p53 effectors—TP53—malignant glioma	0.00063	0.00162	CbGpPWpGaD
Calcitriol—GC—Metabolism—NCOR1—malignant glioma	0.000608	0.00156	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000594	0.00153	CbGpPWpGaD
Calcitriol—VDR—Generic Transcription Pathway—NOTCH1—malignant glioma	0.000552	0.00142	CbGpPWpGaD
Calcitriol—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	0.000552	0.00142	CbGpPWpGaD
Calcitriol—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	0.000544	0.0014	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000541	0.00139	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000523	0.00134	CbGpPWpGaD
Calcitriol—VDR—Generic Transcription Pathway—PPARG—malignant glioma	0.000521	0.00134	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—GSTT1—malignant glioma	0.00051	0.00131	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—H3F3A—malignant glioma	0.00051	0.00131	CbGpPWpGaD
Calcitriol—GC—Metabolism—CAV1—malignant glioma	0.000496	0.00127	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—NOTCH3—malignant glioma	0.000479	0.00123	CbGpPWpGaD
Calcitriol—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	0.000478	0.00123	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PTGS1—malignant glioma	0.000478	0.00123	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000476	0.00122	CbGpPWpGaD
Calcitriol—GC—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000474	0.00122	CbGpPWpGaD
Calcitriol—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	0.000472	0.00121	CbGpPWpGaD
Calcitriol—GC—Metabolism—PIK3CG—malignant glioma	0.000452	0.00116	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—BCHE—malignant glioma	0.000444	0.00114	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—SLC5A5—malignant glioma	0.000439	0.00113	CbGpPWpGaD
Calcitriol—GC—Metabolism—PPARG—malignant glioma	0.000436	0.00112	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—NOTCH2—malignant glioma	0.000429	0.0011	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000415	0.00106	CbGpPWpGaD
Calcitriol—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	0.000414	0.00106	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000411	0.00106	CbGpPWpGaD
Calcitriol—GC—Metabolism—PIK3CD—malignant glioma	0.000397	0.00102	CbGpPWpGaD
Calcitriol—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.000387	0.000993	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—CDKN2B—malignant glioma	0.000369	0.000947	CbGpPWpGaD
Calcitriol—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.000363	0.00093	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000358	0.00092	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—GSTP1—malignant glioma	0.000353	0.000907	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—NCOR1—malignant glioma	0.00035	0.000898	CbGpPWpGaD
Calcitriol—GC—Metabolism—PIK3CB—malignant glioma	0.000346	0.000888	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—CAT—malignant glioma	0.000344	0.000883	CbGpPWpGaD
Calcitriol—GC—Metabolism—PTGS2—malignant glioma	0.000343	0.00088	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—NCOR1—malignant glioma	0.000325	0.000833	CbGpPWpGaD
Calcitriol—GC—Metabolism—PTEN—malignant glioma	0.000299	0.000767	CbGpPWpGaD
Calcitriol—VDR—Generic Transcription Pathway—MYC—malignant glioma	0.000297	0.000762	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—RTEL1—malignant glioma	0.000271	0.000696	CbGpPWpGaD
Calcitriol—CYP3A4—Biological oxidations—GSTP1—malignant glioma	0.000268	0.000688	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—NOTCH1—malignant glioma	0.000266	0.000682	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—CAV1—malignant glioma	0.000265	0.000679	CbGpPWpGaD
Calcitriol—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	0.000264	0.000679	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000253	0.000649	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—PPARG—malignant glioma	0.000251	0.000644	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PIK3CG—malignant glioma	0.000241	0.000619	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PPARG—malignant glioma	0.000233	0.000597	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PIK3CD—malignant glioma	0.000212	0.000544	CbGpPWpGaD
Calcitriol—GC—Metabolism—PIK3CA—malignant glioma	0.000211	0.000541	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PIK3CB—malignant glioma	0.000185	0.000474	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PTGS2—malignant glioma	0.000183	0.00047	CbGpPWpGaD
Calcitriol—GC—Metabolism—AKT1—malignant glioma	0.000172	0.000442	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PTEN—malignant glioma	0.00016	0.00041	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—COX8A—malignant glioma	0.000156	0.0004	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—MYC—malignant glioma	0.000143	0.000367	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—ASMT—malignant glioma	0.000132	0.00034	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—BCAN—malignant glioma	0.000124	0.00032	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—PIK3CA—malignant glioma	0.000113	0.000289	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—IDH2—malignant glioma	0.0001	0.000258	CbGpPWpGaD
Calcitriol—VDR—Gene Expression—AKT1—malignant glioma	9.92e-05	0.000255	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—CYP2B6—malignant glioma	9.43e-05	0.000242	CbGpPWpGaD
Calcitriol—CYP24A1—Metabolism—AKT1—malignant glioma	9.2e-05	0.000236	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—IDH1—malignant glioma	8.63e-05	0.000221	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—SPHK1—malignant glioma	8.35e-05	0.000214	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—CYP2C18—malignant glioma	8.18e-05	0.00021	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—GSTT1—malignant glioma	6.62e-05	0.00017	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PTGS1—malignant glioma	6.2e-05	0.000159	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—BCHE—malignant glioma	5.76e-05	0.000148	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—SLC5A5—malignant glioma	5.69e-05	0.000146	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—GSTP1—malignant glioma	4.59e-05	0.000118	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—CAT—malignant glioma	4.46e-05	0.000115	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—NCOR1—malignant glioma	4.21e-05	0.000108	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—CAV1—malignant glioma	3.44e-05	8.82e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PIK3CG—malignant glioma	3.13e-05	8.03e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PPARG—malignant glioma	3.02e-05	7.75e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PIK3CD—malignant glioma	2.75e-05	7.06e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PIK3CB—malignant glioma	2.4e-05	6.15e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PTGS2—malignant glioma	2.38e-05	6.1e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PTEN—malignant glioma	2.07e-05	5.32e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.46e-05	3.75e-05	CbGpPWpGaD
Calcitriol—CYP3A4—Metabolism—AKT1—malignant glioma	1.19e-05	3.06e-05	CbGpPWpGaD
